Who
Frederic Guerard
Director
Company insider
Files Form 4 as: Chief Executive Officer, CalciMedica; Director, LENZ Therapeutics.
In numbers
- Trades disclosed
- 41
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 8 Dec 2020
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 Jun 2026filed 15 Jun 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,100 at $0.00 | filing |
| 15 Jun 2026filed 15 Jun 2026 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,100 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 11 Jun 2025filed 11 Jun 2025 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 27 Aug 2024filed 28 Aug 2024 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 28 Mar 2024filed 22 Apr 2024 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,897 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,571 at $0.00 | filing |
| 21 Mar 2024filed 25 Mar 2024 | LENZ LENZ Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 23 Mar 2023filed 27 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code D | —83,705 | filing |
| 23 Mar 2023filed 27 Mar 2023 | CALC CalciMedicaBiotechnology | SEC FORM 4 Code D | —83,705 | filing |
| 23 Mar 2023filed 27 Mar 2023 | CALC CalciMedicaBiotechnology | SEC FORM 4 Code F | $112K20,383 at $5.50 | filing |
| 3 Mar 2023filed 6 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code M | —28,125 at $0.00 | filing |
| 3 Mar 2023filed 6 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code M | —221,746 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.